文献速递生殖医学

黄体期刺激后出生子代至三岁时先天性异常随访研究:2208例分析

A follow-up study on congenital anomalies in 2208 offspring of three years old born after luteal-phase stimulation.
PubMed 文献 · Reprod Biomed Online · 2022-04-22

本研究对黄体期刺激(LPS)方案后出生的子代进行随访,比较其与短效激动剂方案子代至三岁时先天性异常、体格生长和健康状况。结果显示两组先天性异常总患病率无差异,LPS组单胎肌肉骨骼系统异常比例显著较低、多胎消化系统异常比例显著较高。结论初步证实LPS长期安全性,但需更大样本长期随访。

要点

  • LPS组与短效激动剂组子代先天性异常总患病率无显著差异。
  • LPS组单胎肌肉骨骼系统异常比例显著较低(P=0.020)。
  • LPS组多胎消化系统异常比例显著较高(P=0.028)。

核心结论

  • LPS方案后出生子代至三岁时先天性异常总发生率未升高,体格生长和健康状况两组 broadly similar,初步证实LPS长期安全性。

研究设计与样本

  • 队列研究,纳入LPS后出生的子代及其父母664对,短效激动剂方案后出生的子代及其父母1308对,随访至子代3岁。

主要发现

  • 先天性异常总患病率两组无差异。
  • LPS组单胎肌肉骨骼系统先天性异常比例显著较低(P=0.020)。
  • LPS组多胎消化系统先天性异常比例显著较高(P=0.028)。
  • 体格生长和健康状况评估两组无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出需进一步开展更大样本量的长期随访以获得更可信的证据和更准确的结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What is the long-term safety in terms of congenital anomalies of a luteal-phase stimulation (LPS) protocol? DESIGN: In this cohort study, 664 couples and their children born after LPS and 1308 couples and their children born after a short agonist protocol were recruited. To investigate the long-term safety of LPS in terms of the prevalence of congenital anomalies, the physical growth and the health status of the offspring, the follow-up was divided into three steps: preparations before follow-up, first-stage follow-up including four telephone interviews, and second-stage follow-up when the children were aged 3 years. RESULTS: The total prevalence of congenital anomalies did not differ between groups. The detailed classification showed a significantly lower percentage of musculoskeletal system congenital anomalies in singletons (P = 0.020) and an obviously higher percentage of digestive system congenital anomalies in multiple births (P = 0.028), both in the LPS group. In the evaluation of physical growth and health status, no significant differences were discovered between the two groups. CONCLUSIONS: This study showed that offspring born after the LPS protocol did not exhibit an elevated rate of total congenital anomalies up to the age of 3. In addition, indicators regarding physical growth and health status were broadly similar between the two groups. These results have preliminarily confirmed the long-term safety of LPS. A subsequent long-term follow-up with a larger sample size should be carried out to generate more convincing evidence and more accurate conclusions.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Jiang S, Chen L, Cai R, et al. A follow-up study on congenital anomalies in 2208 offspring of three years old born after luteal-phase stimulation. Reprod Biomed Online. 2022. PMID: 35810082. doi:10.1016/j.rbmo.2022.04.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。